DEA Extends Prescribing Controlled Substances Via Telehealth For 6 Months

May 11, 2023

The U.S. Drug Enforcement Administration (DEA) is extending the ability for physicians to prescribe controlled substances based on telehealth visits through November 11, 2023. This method had been set to expire when the COVID-19 Public Health Emergency ended today (May 11).  

On March 1, the DEA and the Department of Health and Human Services (HHS), sent out notices of proposed rulemakings (NPRMs) to generate feedback on proposals to continue allowing the prescribing of controlled medications via virtual visits with patients. More than 38,000 public comments came in.  

“These medications, including those used to treat opioid use disorder, are a vital form of care for millions of Americans who have come to rely on safe and effective telemedicine appointments,” said the AMA in a statement. “Patients being treated with these medications often have challenges securing and traveling to in-person appointments.” 

Latest News

Federal Budget Bill Will Have Significant Impact on Minnesota Healthcare

July 10, 2025

With the passage of President Trump’s budget bill, many in healthcare are wondering how it will affect the practice of medicine in the United States, and how it will impact the health of Minnesotans. 

Allina Providers Vote to Authorize Strike

July 10, 2025

With an overwhelming 90% vote of support, Allina Health physicians, physicians’ assistants, and nurse practitioners voted to authorize a strike if the members of the Doctors Council – SEIU and Allina cannot reach a deal.  

Equitable Health Care Task Force Seeks Public Comment

July 10, 2025

The Minnesota Department of Health’s (MDH) Equitable Health Care Task Force is seeking public comment on its draft recommendations for improving health equity across the state.